Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(0.42%)
USD 1.19
(0.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -306.73 Million USD | -3.3% |
| 2022 | -296.93 Million USD | -63.85% |
| 2021 | -181.22 Million USD | -716.34% |
| 2020 | 29.4 Million USD | 137.78% |
| 2019 | -77.81 Million USD | 24.12% |
| 2018 | -102.56 Million USD | -11.25% |
| 2017 | -92.18 Million USD | -23.95% |
| 2016 | -74.37 Million USD | -134.65% |
| 2015 | -31.69 Million USD | 52.09% |
| 2014 | -66.16 Million USD | 16.56% |
| 2013 | -79.29 Million USD | 16.06% |
| 2012 | -94.46 Million USD | 13.64% |
| 2011 | -109.38 Million USD | 21.96% |
| 2010 | -140.16 Million USD | -59.82% |
| 2009 | -87.7 Million USD | -100.45% |
| 2008 | -43.75 Million USD | -103.34% |
| 2007 | -21.51 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -78.17 Million USD | 4.68% |
| 2024 Q2 | -173.31 Million USD | -121.7% |
| 2023 Q2 | -69.83 Million USD | 13.94% |
| 2023 Q1 | -81.14 Million USD | -1.64% |
| 2023 Q4 | -82.01 Million USD | -22.65% |
| 2023 Q3 | -66.86 Million USD | 4.24% |
| 2023 FY | -306.73 Million USD | -3.3% |
| 2022 Q3 | -83.6 Million USD | -17.1% |
| 2022 Q2 | -71.39 Million USD | 15.42% |
| 2022 Q4 | -79.84 Million USD | 4.5% |
| 2022 FY | -296.93 Million USD | -63.85% |
| 2022 Q1 | -84.41 Million USD | -21.76% |
| 2021 FY | -181.22 Million USD | -716.34% |
| 2021 Q1 | -87.43 Million USD | -216.68% |
| 2021 Q2 | -41 Million USD | 53.11% |
| 2021 Q3 | 16.54 Million USD | 140.35% |
| 2021 Q4 | -69.32 Million USD | -519.11% |
| 2020 Q3 | -23.7 Million USD | -2.69% |
| 2020 Q2 | -23.08 Million USD | -1929.32% |
| 2020 Q1 | 1.26 Million USD | 1486.81% |
| 2020 FY | 29.4 Million USD | 137.78% |
| 2020 Q4 | 74.93 Million USD | 416.07% |
| 2019 FY | -77.81 Million USD | 24.12% |
| 2019 Q1 | -30.32 Million USD | 1.54% |
| 2019 Q2 | -24.59 Million USD | 18.89% |
| 2019 Q3 | -29.12 Million USD | -18.41% |
| 2019 Q4 | -91 Thousand USD | 99.69% |
| 2018 Q3 | -25.04 Million USD | -11.11% |
| 2018 Q1 | -24.17 Million USD | -16.46% |
| 2018 FY | -102.56 Million USD | -11.25% |
| 2018 Q4 | -30.79 Million USD | -22.98% |
| 2018 Q2 | -22.54 Million USD | 6.78% |
| 2017 Q1 | -23.86 Million USD | -25.42% |
| 2017 FY | -92.18 Million USD | -23.95% |
| 2017 Q4 | -20.76 Million USD | 5.72% |
| 2017 Q3 | -22.02 Million USD | 13.78% |
| 2017 Q2 | -25.53 Million USD | -7.01% |
| 2016 Q2 | -18.49 Million USD | 4.41% |
| 2016 Q3 | -17.49 Million USD | 5.43% |
| 2016 Q4 | -19.03 Million USD | -8.78% |
| 2016 FY | -74.37 Million USD | -134.65% |
| 2016 Q1 | -19.35 Million USD | -1273.46% |
| 2015 Q4 | -1.4 Million USD | -177.38% |
| 2015 Q1 | -20.17 Million USD | -6.31% |
| 2015 Q2 | -11.93 Million USD | 40.84% |
| 2015 Q3 | 1.82 Million USD | 115.26% |
| 2015 FY | -31.69 Million USD | 52.09% |
| 2014 Q3 | -9.16 Million USD | 52.12% |
| 2014 Q1 | -18.88 Million USD | -9.6% |
| 2014 FY | -66.16 Million USD | 16.56% |
| 2014 Q4 | -18.97 Million USD | -107.08% |
| 2014 Q2 | -19.13 Million USD | -1.32% |
| 2013 Q4 | -17.23 Million USD | 15.89% |
| 2013 Q3 | -20.48 Million USD | -0.08% |
| 2013 Q2 | -20.47 Million USD | 3.0% |
| 2013 Q1 | -21.1 Million USD | 2.61% |
| 2013 FY | -79.29 Million USD | 16.06% |
| 2012 Q1 | -27.58 Million USD | -20.84% |
| 2012 Q2 | -22.48 Million USD | 18.47% |
| 2012 Q4 | -21.66 Million USD | 4.66% |
| 2012 Q3 | -22.72 Million USD | -1.08% |
| 2012 FY | -94.46 Million USD | 13.64% |
| 2011 Q2 | -22.47 Million USD | 35.43% |
| 2011 Q1 | -34.8 Million USD | 4.42% |
| 2011 FY | -109.38 Million USD | 21.96% |
| 2011 Q4 | -22.82 Million USD | 22.06% |
| 2011 Q3 | -29.28 Million USD | -30.28% |
| 2010 Q3 | -40.7 Million USD | -24.44% |
| 2010 Q4 | -36.41 Million USD | 10.54% |
| 2010 Q1 | -30.32 Million USD | -8.06% |
| 2010 FY | -140.16 Million USD | -59.82% |
| 2010 Q2 | -32.71 Million USD | -7.88% |
| 2009 Q4 | -28.06 Million USD | -14.41% |
| 2009 FY | -87.7 Million USD | -100.45% |
| 2009 Q3 | -24.52 Million USD | 0.0% |
| 2008 FY | -43.75 Million USD | -103.34% |
| 2007 FY | -21.51 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | -397.801% |
| BrainsWay Ltd. | -4.19 Million USD | -7208.435% |
| Cerus Corporation | -37.48 Million USD | -718.2% |
| Envoy Medical, Inc. | -29.9 Million USD | -925.595% |
| electroCore, Inc. | -18.83 Million USD | -1528.624% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -3365.932% |
| IceCure Medical Ltd | -14.65 Million USD | -1993.468% |
| Inogen, Inc. | -102.44 Million USD | -199.403% |
| OrthoPediatrics Corp. | -20.97 Million USD | -1362.454% |
| Lucid Diagnostics Inc. | -52.66 Million USD | -482.416% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -2131.576% |
| MaxCyte, Inc. | -37.92 Million USD | -708.836% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -2486.409% |
| Nexalin Technology, Inc. | -4.64 Million USD | -6498.284% |
| Orthofix Medical Inc. | -151.39 Million USD | -102.606% |
| PAVmed Inc | -64.17 Million USD | -377.966% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | -484.625% |
| RxSight, Inc. | -48.6 Million USD | -531.038% |
| Sight Sciences, Inc. | -55.54 Million USD | -452.208% |
| SI-BONE, Inc. | -43.33 Million USD | -607.806% |
| TELA Bio, Inc. | -46.66 Million USD | -557.327% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | -519.329% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -2158.227% |
| Acutus Medical, Inc. | -81.66 Million USD | -275.611% |
| Talis Biomedical Corporation | -62 Million USD | -394.678% |
| Spectral AI, Inc. | -20.85 Million USD | -1370.869% |
| Nano-X Imaging Ltd. | -60.77 Million USD | -404.698% |
| CVRx, Inc. | -41.19 Million USD | -644.52% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 48012.67% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -2699.879% |
| Bioventus Inc. | -156.23 Million USD | -96.336% |
| Venus Concept Inc. | -37.25 Million USD | -723.45% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | -419.555% |
| LivaNova PLC | 17.54 Million USD | 1848.176% |
| 908 Devices Inc. | -36.39 Million USD | -742.702% |
| Alphatec Holdings, Inc. | -186.63 Million USD | -64.348% |
| Nemaura Medical Inc. | -14.14 Million USD | -2068.699% |
| NeuroPace, Inc. | -32.95 Million USD | -830.741% |
| LENSAR, Inc. | -14.38 Million USD | -2032.622% |
| Apyx Medical Corporation | -18.71 Million USD | -1539.155% |
| Cutera, Inc. | -162.83 Million USD | -88.374% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -2732.271% |
| BioSig Technologies, Inc. | -29.04 Million USD | -956.214% |
| Anika Therapeutics, Inc. | -82.66 Million USD | -271.049% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -1288.632% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 552.806% |
| Axonics, Inc. | -6.08 Million USD | -4938.354% |
| Outset Medical, Inc. | -172.79 Million USD | -77.512% |
| IRIDEX Corporation | -9.57 Million USD | -3105.172% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | -189.654% |
| IRadimed Corporation | 17.19 Million USD | 1884.092% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -3620.706% |
| INVO Bioscience, Inc. | -8.03 Million USD | -3717.67% |
| Telesis Bio, Inc. | -47.72 Million USD | -542.727% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 3094.582% |
| Varex Imaging Corporation | -47.7 Million USD | -543.05% |
| Quipt Home Medical Corp. | -2.78 Million USD | -10917.78% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -2617.836% |
| Pulmonx Corporation | -60.84 Million USD | -404.142% |
| Dynatronics Corporation | -2.69 Million USD | -11270.161% |
| Modular Medical, Inc. | -17.47 Million USD | -1655.781% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -2593.73% |
| Semler Scientific, Inc. | 20.58 Million USD | 1590.235% |
| InMode Ltd. | 197.91 Million USD | 254.98% |
| Bruker Corporation | 427.2 Million USD | 171.801% |
| Cytosorbents Corporation | -28.5 Million USD | -975.984% |
| DexCom, Inc. | 541.5 Million USD | 156.645% |
| Align Technology, Inc. | 445.05 Million USD | 168.921% |
| Viveve Medical, Inc. | -22.02 Million USD | -1292.541% |
| ZimVie Inc. | -393.28 Million USD | 22.006% |
| Movano Inc. | -29.28 Million USD | -947.485% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -2424.984% |
| Nexalin Technology, Inc. | -4.64 Million USD | -6498.284% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 48012.67% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | -37.79% |
| Profound Medical Corp. | -28.56 Million USD | -973.664% |
| Insulet Corporation | 206.3 Million USD | 248.684% |
| enVVeno Medical Corporation | -23.51 Million USD | -1204.367% |
| Surmodics, Inc. | -11.54 Million USD | -2557.555% |
| iCAD, Inc. | -4.84 Million USD | -6228.347% |
| Nuwellis, Inc. | -20.2 Million USD | -1417.814% |
| Biotricity, Inc. | -14.09 Million USD | -2076.308% |
| iRhythm Technologies, Inc. | -123.4 Million USD | -148.558% |
| Aethlon Medical, Inc. | -12.2 Million USD | -2412.538% |
| InspireMD, Inc. | -19.91 Million USD | -1440.144% |
| PAVmed Inc. | -64.17 Million USD | -377.966% |
| BIOLASE, Inc. | -20.63 Million USD | -1386.695% |
| Beyond Air, Inc. | -60.24 Million USD | -409.171% |
| FONAR Corporation | 10.56 Million USD | 3002.655% |
| AxoGen, Inc. | -21.71 Million USD | -1312.484% |
| Vivani Medical, Inc. | -25.65 Million USD | -1095.755% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 1175.697% |
| Inari Medical, Inc. | -1.63 Million USD | -18649.083% |
| UFP Technologies, Inc. | 44.92 Million USD | 782.786% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -5876.523% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -4543.836% |
| Tenon Medical, Inc. | -15.58 Million USD | -1868.648% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -1888.429% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -768.129% |
| AdaptHealth Corp. | -678.89 Million USD | 54.818% |
| Sintx Technologies, Inc. | -8.25 Million USD | -3613.948% |
| NanoVibronix, Inc. | -3.71 Million USD | -8165.562% |
| Quanterix Corporation | -32.33 Million USD | -848.645% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -2617.836% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 63344.33% |
| TransMedics Group, Inc. | -25.02 Million USD | -1125.567% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -1285.872% |
| NeuroMetrix, Inc. | -6.52 Million USD | -4597.689% |
| Hyperfine, Inc. | -44.23 Million USD | -593.374% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | -290.735% |
| Biomerica, Inc. | -5.97 Million USD | -5031.064% |
| Bone Biologics Corporation | -8.94 Million USD | -3327.693% |
| AVITA Medical, Inc. | -39.16 Million USD | -683.122% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -2981.56% |
| Silk Road Medical, Inc | -55.74 Million USD | -450.266% |